Denali Therapeutics has announced positive results from its first-in-human LRRK2 inhibitor clinical trial. The trial concluded that the experimental t...
A group of scientists led by researchers from the National Institutes of Health published a paper describing how they identified 28 genetic risk facto...
Today we share the research of Professor Glenda Halliday and Dr Nicholas Dzamko and the world leading LKK2 research they are conducting at The Univers...
As research forges ahead, scientists must take into account the possibility of various factors working in tandem to place a person at greater risk for...
The below post is written by Genia Brin, mother of internet entrepreneur and Google Co-Founder Sergey Brin. Care of the Michael J Fox Foundation, Geni...
Last week, The Michael J. Fox Foundation (MJFF) hosted a workshop to delve deeper into understanding how specific mutations in a gene called glucocer...
Two genes related to protein accumulation in the brains of people with Parkinson’s disease can indicate how quickly the disease will progress in an ...